in insulin-dependent diabetics , beta-blockers can prolong , enhance , or alter the symptoms of hypoglycemia , while hyperglycemia appears to be the major risk in noninsulin-dependent diabetics . beta-blockers can potentially increase blood glucose concentrations and antagonize the action of oral hypoglycemic drugs .
C0021641
insulin
C0020456
hyperglycemia